Source:http://linkedlifedata.com/resource/pubmed/id/18600415
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2008-7-7
|
| pubmed:abstractText |
(18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0914-7187
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
379-85
|
| pubmed:meshHeading |
pubmed-meshheading:18600415-Female,
pubmed-meshheading:18600415-Fluorodeoxyglucose F18,
pubmed-meshheading:18600415-Humans,
pubmed-meshheading:18600415-Male,
pubmed-meshheading:18600415-Mass Screening,
pubmed-meshheading:18600415-Middle Aged,
pubmed-meshheading:18600415-Neoplasms,
pubmed-meshheading:18600415-Pilot Projects,
pubmed-meshheading:18600415-Radiopharmaceuticals,
pubmed-meshheading:18600415-Reproducibility of Results,
pubmed-meshheading:18600415-Sensitivity and Specificity,
pubmed-meshheading:18600415-Whole Body Imaging
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
|
| pubmed:affiliation |
Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. tterauch@ncc.go.jp
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|